Cargando…
Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
Autores principales: | Del Papa, Nicoletta, Sambataro, Gianluca, Minniti, Antonina, Pignataro, Francesca, Caporali, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198424/ https://www.ncbi.nlm.nih.gov/pubmed/32380317 http://dx.doi.org/10.1016/j.autrev.2020.102558 |
Ejemplares similares
-
High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2020) -
Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2020) -
Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity
por: Minniti, Antonina, et al.
Publicado: (2020) -
NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity
por: Pignataro, Francesca, et al.
Publicado: (2019) -
Instruments for Outcome Evaluation of Specific Domains in Primary Sjögren’s Syndrome
por: Del Papa, Nicoletta, et al.
Publicado: (2021)